Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingkun Xu

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Biomed Research International|February 28, 2020
Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell CarcinomaJianyi Li, Guangzhen Wu, Yingkun Xu, et al.
Biomed Research International|September 13, 2021
A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell CarcinomaXiaochen Qi, Xin Lv, Xiaoxi Wang, et al.
Translational Cancer Research|September 12, 2024
Comprehensive pan-cancer analysis reveals CDC6 as a potential immunomodulatory agent and promising therapeutic target in pancreatic cancerDongyao Pu, Yingkun Xu, Haochen Yu, et al.
Clinical and Translational Medicine|May 4, 2023
The mechanism of liver X receptor regulates the balance of glycoFAsynthesis and cholesterol synthesis in clear cell renal cell carcinomaQifei Wang, Wei Zhang, Xiaochen Qi, et al.
Journal of Personalized Medicine|January 21, 2023
Comprehensive Analysis of Necroptosis-Related Genes as Prognostic Factors and Immunological Biomarkers in Breast CancerYingkun Xu, Qiulin Wu, Zhenrong Tang, et al.
Frontiers in Genetics|July 29, 2022
The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for PatientsZicheng Wang, Jiayi Li, Peizhi Zhang, et al.
Frontiers in Oncology|March 27, 2023
Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysisPeizhi Zhang, Jiayi Li, Zicheng Wang, et al.
BMC Urology|March 28, 2023
Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinomaJiechuan Qiu, Zicheng Wang, Yingkun Xu, et al.
Journal of Immunology Research|February 25, 2021
Identification of a New Prognostic Risk Signature of Clear Cell Renal Cell Carcinoma Based on N<sup>6</sup>-Methyladenosine RNA Methylation RegulatorsYan Zhang, Yao Yao, Xiaochen Qi, et al.
Biomed Research International|October 16, 2020
Roles of Reactive Oxygen Species in Biological Behaviors of Prostate CancerChenglin Han, Zilong Wang, Yingkun Xu, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Biomed Research International|February 28, 2020
Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell CarcinomaJianyi Li, Guangzhen Wu, Yingkun Xu, et al.
Biomed Research International|September 13, 2021
A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell CarcinomaXiaochen Qi, Xin Lv, Xiaoxi Wang, et al.
Translational Cancer Research|September 12, 2024
Comprehensive pan-cancer analysis reveals CDC6 as a potential immunomodulatory agent and promising therapeutic target in pancreatic cancerDongyao Pu, Yingkun Xu, Haochen Yu, et al.
Clinical and Translational Medicine|May 4, 2023
The mechanism of liver X receptor regulates the balance of glycoFAsynthesis and cholesterol synthesis in clear cell renal cell carcinomaQifei Wang, Wei Zhang, Xiaochen Qi, et al.
Journal of Personalized Medicine|January 21, 2023
Comprehensive Analysis of Necroptosis-Related Genes as Prognostic Factors and Immunological Biomarkers in Breast CancerYingkun Xu, Qiulin Wu, Zhenrong Tang, et al.
Frontiers in Genetics|July 29, 2022
The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for PatientsZicheng Wang, Jiayi Li, Peizhi Zhang, et al.
Frontiers in Oncology|March 27, 2023
Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysisPeizhi Zhang, Jiayi Li, Zicheng Wang, et al.
BMC Urology|March 28, 2023
Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinomaJiechuan Qiu, Zicheng Wang, Yingkun Xu, et al.
Journal of Immunology Research|February 25, 2021
Identification of a New Prognostic Risk Signature of Clear Cell Renal Cell Carcinoma Based on N<sup>6</sup>-Methyladenosine RNA Methylation RegulatorsYan Zhang, Yao Yao, Xiaochen Qi, et al.
Biomed Research International|October 16, 2020
Roles of Reactive Oxygen Species in Biological Behaviors of Prostate CancerChenglin Han, Zilong Wang, Yingkun Xu, et al.
Pageof 7